0xa0f2c22b…658353880xa0f2c22b8e03e02809c27736e8b4804665835388Every view this brain has held, sealed with a hash of its own contents and the hash of the version before it. Nothing here is edited after the fact — a revised thesis becomes a new version, and the old one stays readable.
Evidence accumulated under 1 concept without changing any status. The shape of the thesis held.
V2 and V1 are not consecutive, so V1’s declared predecessor is V0 rather than the version on the left. The badge verifies that link; the comparison below is still between the two versions you picked.
Nothing in Salesforce, Inc.'s filings yet holds the thesis up on its own. The largest figures on record: Equity investments at $1.5B (FY2026). Working against it: customer financing exposure — 3 disclosures land against customer financing exposure alone. Nothing filed has yet landed on export controls and China exposure and supply chain dependency in either direction, so they remain part of the thesis that the record does not speak to. On the balance of what has been filed, the supporting evidence is clearly the weaker side (0/100), held as a stable brain at low confidence, because the evidence is still thin or still divided. A further 23 disclosures have been read and attached but not resolved for or against the thesis, so none of it moves the score. Nearest unanswered question: does this disclosure strengthen or weaken regulatory and legal exposure?
Nothing in Salesforce, Inc.'s filings yet holds the thesis up on its own. The largest figures on record: Equity investments at $1.5B (FY2026). Working against it: customer financing exposure — 1 disclosure lands against customer financing exposure alone. Nothing filed has yet landed on export controls and China exposure and supply chain dependency in either direction, so they remain part of the thesis that the record does not speak to. On the balance of what has been filed, the supporting evidence is clearly the weaker side (0/100), held as a stable brain at low confidence, because the evidence is still thin or still divided. A further 22 disclosures have been read and attached but not resolved for or against the thesis, so none of it moves the score. Nearest unanswered question: does this disclosure strengthen or weaken regulatory and legal exposure?
Status held, but the balance underneath it moved.
2 contradicting items aged out.
Every concept in either version, including the ones that did not move.
2 contradicting items aged out.
Newest first. Each entry declares the hash of its predecessor, and the link is checked against the version actually on file.
Nothing holds the thesis up; customer financing exposure works against it. Integrity 0/100 at low confidence, from 3 directional items. Composed by deterministic-v1 from extracted facts; no interpretation beyond the rules that produced them.
Nothing holds the thesis up; customer financing exposure works against it. Integrity 0/100 at low confidence, from 1 directional item. Composed by deterministic-v1 from extracted facts; no interpretation beyond the rules that produced them.
Versions are never edited. Each one stores a sha256 of its own contents and the hash of the version before it, so a change to any earlier version would break every link after it.
StockBrain publishes model-generated research interpretations, not investment advice, recommendations, or forecasts. Evidence is linked to primary sources so every claim can be checked.